Exclusive special offer and discount title banner vector image

GLOBAL DRY EYE DISEASE MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

Global Dry Eye Disease Market by Type (OTC, Prescription) Market by Product (Anti-inflammatory Drugs (Cyclosporine, Corticosteroid, Other Anti-inflammatory Drugs), Artificial Tears, Punctal Plugs, Secretagogues, Other Products) Market by Distribution Channel (Hospital Pharmacies, Independent Pharmacies and Drugstores, Online Pharmacies) by Geography


MARKET OVERVIEW

The global dry eye disease market was valued at $5346.84 million in 2022 and is expected to reach $8884.34 million by 2032, growing at a CAGR of 5.11% during the forecast period, 2023-2032. The base year considered for the study is 2022, and the estimated period is between 2023 and 2032. The market study has also analyzed the impact of COVID-19 on the dry eye disease market qualitatively and quantitatively.

Dry eye syndrome is a chronic and progressive condition caused by a lack of tears to lubricate the eyes. Tears are crucial for maintaining good eye health and vision. The syndrome is commonly seen in older people and those who spend prolonged periods in front of computer screens. Factors contributing to dry eye include age, medications, environmental conditions, and long-term contact lens use. While there is no complete cure for dry eye, medical products can help manage the condition.

Further, dry eye disease is a complex and multifactorial condition with risks ranging from intermittent discomfort to a serious, chronic, and irreversible vision-threatening disorder. The incidence of dry eyes increases with age, and aging populations worldwide contribute to increased treatment demands. Changing work and leisure patterns have also contributed to the increased demand for treatment, as more people spend significant time using digital devices. 

Moreover, the demand for dry eye disease treatment is also rising in emerging economies due to expanding urban and professional populations and greater access to healthcare and resources. Additionally, sophisticated diagnostic tools and a wider range of dry eye products and treatments, such as artificial tear products, provide better relief and stimulate demand.

Read our latest blog on the Dry Eye Disease Market

GROWTH ENABLERS

Key growth enablers of the global dry eye disease market growth are: 

  • Introduction of novel diagnostic techniques for dry eye disease 
  • Launch of promising pipeline products for dry eye disease 
  • Growing incidence and prevalence of dry eye among different age groups
    • According to the National Institute of Health (NIH), dry eye disease (DED) is the most common eye disease worldwide, particularly in densely populated countries like China. Factors such as changing lifestyles and aging have made DED a significant public health concern. 
    • Further, countries worldwide are adopting new techniques for the safe and effective treatment of older individuals, leading to decreased death rates and a significant increase in the elderly population globally. For instance, in 2019, there were 703 million individuals aged 65 and above, which is expected to double to 1.5 billion by 2050.
    • Besides, the healthcare industry’s advancements have resulted in the availability of various high-tech facilities, leading to increased life expectancy. 

GROWTH RESTRAINTS

Key growth restraining factors of the global dry eye disease market are:

  • Risk of side effects
    • Side effects caused by eye drops include blurred vision, increased sensitivity, watering eyes, redness, swelling of eyelids, sticky eyelashes, and discomfort. The side effects may vary from one individual to another. 
    • Dozens of infections, cases of vision loss, and even surgical removal of eyes have been linked to a rare strain of bacteria found in recalled eye drops. In 2023, the United States Centres for Disease Control and Prevention confirmed two more deaths, bringing the total number of fatalities linked to this bacterial infection to three.
  • Substitute therapies
  • Expensive specialty products and complex reimbursement scenario

To Know More About This Report, Request a Free Sample Copy

KEY MARKET TRENDS

Global Dry Eye Disease Market | Top Trends
  • Stem cell therapy is aiding the development of technologies that help treat dry eyes. The aim is to limit disease progression, promote regeneration, and sustain corneal clarity. For instance, scientists are investigating the potential of cytokines and diverse cell sources, including mesenchymal stem cells, to treat dry eye conditions efficiently. Recently, in April 2022, a team of scientists led by Osaka University in Japan collaborated with researchers from Cardiff University’s School of Optometry and Vision Sciences to conduct a study. The study revealed a technique for producing miniature lacrimal glands using induced pluripotent stem cells (iPS), which can alleviate dry eye disease symptoms.
  • Conducting extensive research on dry eye disease is beneficial for the advancement of drugs and medications. In Europe, the European Dry Eye Network was established under Horizon 2020, serving as a training and career development platform for ten early-stage researchers (ESRs) in Vision Sciences. The network facilitates collaborative research and training efforts among four prominent academic institutions in Europe, offering a unique blend of expertise from various countries.

MARKET SEGMENTATION

Market Segmentation Analysis – Type, Product, and Distribution Channel –

Market by Type:

  • OTC
  • Prescription
    • Prescription is the fastest-growing type in the global dry eye disease market. Patients are encouraged to see an eye professional if extended use of over-the-counter artificial tears does not produce the desired outcome. 
    • Medication that aids in treating chronic eye problems may be found in prescription eye drops recommended by a doctor. However, these eye drops may have side effects and are only available with a valid doctor’s prescription. For instance, corticosteroid medications are widely used by patients and healthcare professionals to treat dry eye conditions. 

 Market by Product:

  • Anti-Inflammatory Drugs
  • Artificial Tears
  • Punctal Plugs
  • Secretagogues
  • Other Products

Market by Distribution Channel:

  • Hospital Pharmacies
    • Hospital pharmacies are the largest revenue-generating distribution channel in the global dry eye disease market. Hospital pharmacies are expanding quickly. Given the frequency of patients in the outpatient department, such services are indispensable. Different departments oversee hospital-related purchases in hospitals, including medications, equipment, and medical supplies. Also, drug sales through hospital pharmacies are rising as more individuals with dry eye disease seek treatment.
    • Moreover, the rising prevalence of dry eye disease contributes to the increased number of hospital visits, thereby promoting the sales of dry eye disease (DED) drugs through hospital pharmacies.
  • Independent Pharmacies and Drugstores
  • Online Pharmacies

GEOGRAPHICAL STUDY

Geographical Study Based on Four Major Regions:
  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Belgium, Poland, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Australia & New Zealand, and Rest of Asia-Pacific
    • Asia-Pacific is the fastest-growing region in the global dry eye disease market.
    • Asian origin people are evaluated to display more severe symptoms of dry eye disease than other ethnic groups. 
    • Also, the region’s population is aging rapidly, with China having the world’s largest number of senior citizens. 
    • Moreover, air pollution is a significant cause of dry eye disease and other eye-related infections in countries such as India, China and Bangladesh.
  • Rest of World: Latin America, the Middle East & Africa

MAJOR PLAYERS

Some of the major players in the global dry eye disease market are:

  • Bausch Health Companies 
  • Allergan Plc (Acquired by AbbVie)
  • Otsuka Pharmaceutical Co Ltd
  • Novartis AG
  • Alcon

Key strategies adopted by some of these companies:

  • In February 2023, AFT Pharmaceuticals declared an agreement with Latitude Pharmaceuticals Inc to acquire a license for Latitude’s essential technology, which will be utilized to develop a secure antibiotic eye drop for patients susceptible to severe eye infections. 
  • In January 2022, Sun Pharma Canada, a wholly-owned subsidiary of Sun Pharmaceutical Industries, announced the launch of CEQUA, a novel treatment option for individuals suffering from dry eye disease in Canada.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments AnalyzedType, Product, Distribution Channel
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies AnalyzedAFT Pharmaceuticals, Alcon, Allergan Plc (Acquired by AbbVie), Bausch Health Companies Inc, Johnson & Johnson, Lumenis, Novaliq GmbH, Novartis AG, OASIS Medical, Otsuka Pharmaceutical Co Ltd, Santen Pharmaceutical Co Ltd, Sentiss Pharma Private Limited, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, VISUfarma

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
    5. MAJOR MARKET FINDINGS
      1. AIR POLLUTION IS A MAJOR CAUSE OF EYE DISEASES
      2. COVID-19 CONTRIBUTED TO A HIGH NUMBER OF DRY EYE DISEASE CASES
      3. ASIAN RACE IS AT HIGHER RISK OF DEVELOPING DRY EYE DISEASE
      4. EXCESSIVE SCREEN TIME CAN INDUCE DRY EYE SYMPTOMS
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. INTRODUCTION OF NOVEL DIAGNOSTIC TECHNIQUES FOR DRY EYE DISEASE 
      2. LAUNCH OF PROMISING PIPELINE PRODUCTS FOR DRY EYE DISEASE 
      3. GROWING INCIDENCE AND PREVALENCE OF DRY EYE AMONG DIFFERENT AGE GROUPS
    2. KEY RESTRAINTS
      1. RISK OF SIDE EFFECTS
      2. SUBSTITUTE THERAPIES
      3. EXPENSIVE SPECIALTY PRODUCTS AND COMPLEX REIMBURSEMENT SCENARIO
  4. KEY ANALYTICS
    1. PARENT MARKET ANALYSIS
    2. KEY MARKET TRENDS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. GROWTH PROSPECT MAPPING
    5. MARKET MATURITY ANALYSIS
    6. MARKET CONCENTRATION ANALYSIS
    7. VALUE CHAIN ANALYSIS
      1. RESEARCH AND DEVELOPMENT
      2. MANUFACTURING
      3. DISTRIBUTORS
      4. POST-SALES MONITORING
  5. MARKET BY TYPE
    1. OTC
    2. PRESCRIPTION
  6. MARKET BY PRODUCT
    1. ANTI-INFLAMMATORY DRUGS
      1. CYCLOSPORINE
      2. CORTICOSTEROID
      3. OTHER ANTI-INFLAMMATORY DRUGS
    2. ARTIFICIAL TEARS
    3. PUNCTAL PLUGS
    4. SECRETAGOGUES
    5. OTHER PRODUCTS
  7. MARKET BY DISTRIBUTION CHANNEL
    1. HOSPITAL PHARMACIES
    2. INDEPENDENT PHARMACIES AND DRUGSTORES
    3. ONLINE PHARMACIES
  8. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA DRY EYE DISEASE MARKET DRIVERS
      3. NORTH AMERICA DRY EYE DISEASE MARKET CHALLENGES
      4. NORTH AMERICA DRY EYE DISEASE MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN NORTH AMERICA DRY EYE DISEASE MARKET
      6. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES 
        2. CANADA
          1. CANADA DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE DRY EYE DISEASE MARKET DRIVERS
      3. EUROPE DRY EYE DISEASE MARKET CHALLENGES
      4. EUROPE DRY EYE DISEASE MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN EUROPE DRY EYE DISEASE MARKET
      6. COUNTRY ANALYSIS
        1. UNITED KINGDOM
          1. UNITED KINGDOM DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES 
        2. GERMANY
          1. GERMANY DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
        3. FRANCE
          1. FRANCE DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES 
        4. ITALY
          1. ITALY DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
        5. BELGIUM
          1. BELGIUM DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES 
        6. SPAIN
          1. SPAIN DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
        7. POLAND
          1. POLAND DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES 
        8. REST OF EUROPE
          1. REST OF EUROPE DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC DRY EYE DISEASE MARKET DRIVERS
      3. ASIA-PACIFIC DRY EYE DISEASE MARKET CHALLENGES
      4. ASIA-PACIFIC DRY EYE DISEASE MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN ASIA-PACIFIC DRY EYE DISEASE MARKET
      6. COUNTRY ANALYSIS
        1. CHINA
          1. CHINA DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES 
        2. JAPAN
          1. JAPAN DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
        4. SOUTH KOREA
          1. SOUTH KOREA DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES 
        5. INDONESIA
          1. INDONESIA DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
        6. THAILAND
          1. THAILAND DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES 
        7. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
        8. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. REST OF WORLD DRY EYE DISEASE MARKET DRIVERS
      3. REST OF WORLD DRY EYE DISEASE MARKET CHALLENGES
      4. REST OF WORLD DRY EYE DISEASE MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN REST OF WORLD DRY EYE DISEASE MARKET
      6. REGIONAL ANALYSIS
        1. LATIN AMERICA
          1. LATIN AMERICA DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
        2. MIDDLE EAST AND AFRICA
          1. MIDDLE EAST AND AFRICA DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. AFT PHARMACEUTICALS
      2. ALCON
      3. ALLERGAN PLC (ACQUIRED BY ABBVIE)
      4. BAUSCH HEALTH COMPANIES INC
      5. JOHNSON & JOHNSON
      6. LUMENIS
      7. NOVALIQ GMBH
      8. NOVARTIS AG
      9. OASIS MEDICAL
      10. OTSUKA PHARMACEUTICAL CO LTD
      11. SANTEN PHARMACEUTICAL CO LTD
      12. SENTISS PHARMA PRIVATE LIMITED
      13. SUN PHARMACEUTICAL INDUSTRIES LTD
      14. TEVA PHARMACEUTICAL INDUSTRIES LTD
      15. VISUFARMA

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – DRY EYE DISEASE

TABLE 2: GLOBAL DRY EYE DISEASE MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: GLOBAL DRY EYE DISEASE MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 4: GLOBAL OTC MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: GLOBAL OTC MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 6: GLOBAL PRESCRIPTION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: GLOBAL PRESCRIPTION MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 8: GLOBAL DRY EYE DISEASE MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: GLOBAL DRY EYE DISEASE MARKET, BY PRODUCT, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 10: GLOBAL DRY EYE DISEASE MARKET, BY ANTI-INFLAMMATORY DRUGS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: GLOBAL DRY EYE DISEASE MARKET, BY ANTI-INFLAMMATORY DRUGS, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 12: GLOBAL CYCLOSPORINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: GLOBAL CYCLOSPORINE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 14: GLOBAL CORTICOSTEROID MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: GLOBAL CORTICOSTEROID MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 16: GLOBAL OTHER ANTI-INFLAMMATORY DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: GLOBAL OTHER ANTI-INFLAMMATORY DRUGS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 18: GLOBAL ARTIFICIAL TEARS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 19: GLOBAL ARTIFICIAL TEARS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 20: GLOBAL PUNCTAL PLUGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 21: GLOBAL PUNCTAL PLUGS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 22: GLOBAL SECRETAGOGUES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 23: GLOBAL SECRETAGOGUES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 24: GLOBAL OTHER PRODUCTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 25: GLOBAL OTHER PRODUCTS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 26: GLOBAL DRY EYE DISEASE MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 27: GLOBAL DRY EYE DISEASE MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 28: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 29: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 30: GLOBAL INDEPENDENT PHARMACIES AND DRUGSTORES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 31: GLOBAL INDEPENDENT PHARMACIES AND DRUGSTORES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 32: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 33: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 34: GLOBAL DRY EYE DISEASE MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 35: GLOBAL DRY EYE DISEASE MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 36: NORTH AMERICA DRY EYE DISEASE MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 37: NORTH AMERICA DRY EYE DISEASE MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 38: NORTH AMERICA DRY EYE DISEASE MARKET REGULATORY FRAMEWORK

TABLE 39: KEY PLAYERS OPERATING IN NORTH AMERICA DRY EYE DISEASE MARKET

TABLE 40: EUROPE DRY EYE DISEASE MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 41: EUROPE DRY EYE DISEASE MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 42: EUROPE DRY EYE DISEASE MARKET REGULATORY FRAMEWORK

TABLE 43: KEY PLAYERS OPERATING IN EUROPE DRY EYE DISEASE MARKET

TABLE 44: ASIA-PACIFIC DRY EYE DISEASE MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 45: ASIA-PACIFIC DRY EYE DISEASE MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 46: ASIA-PACIFIC DRY EYE DISEASE MARKET REGULATORY FRAMEWORK

TABLE 47: KEY PLAYERS OPERATING IN ASIA-PACIFIC DRY EYE DISEASE MARKET

TABLE 48: REST OF WORLD DRY EYE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 49: REST OF WORLD DRY EYE DISEASE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 50: REST OF WORLD DRY EYE DISEASE MARKET REGULATORY FRAMEWORK

TABLE 51: KEY PLAYERS OPERATING IN REST OF WORLD DRY EYE DISEASE MARKET

TABLE 52: LIST OF MERGERS & ACQUISITIONS 

TABLE 53: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 54: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 55: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

 

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR NORTH AMERICA

FIGURE 4: GROWTH PROSPECT MAPPING FOR EUROPE

FIGURE 5: GROWTH PROSPECT MAPPING FOR ASIA-PACIFIC

FIGURE 6: GROWTH PROSPECT MAPPING FOR MEXICO

FIGURE 7: MARKET MATURITY ANALYSIS

FIGURE 8: MARKET CONCENTRATION ANALYSIS

FIGURE 9: VALUE CHAIN ANALYSIS

FIGURE 10: GLOBAL DRY EYE DISEASE MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022

FIGURE 11: GLOBAL DRY EYE DISEASE MARKET, BY OTC, 2023-2032 (IN $ MILLION)

FIGURE 12: GLOBAL DRY EYE DISEASE MARKET, BY PRESCRIPTION, 2023-2032 (IN $ MILLION)

FIGURE 13: GLOBAL DRY EYE DISEASE MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2022

FIGURE 14: GLOBAL DRY EYE DISEASE MARKET, BY ANTI-INFLAMMATORY DRUGS, 2023-2032 (IN $ MILLION)

FIGURE 15: GLOBAL DRY EYE DISEASE MARKET, GROWTH POTENTIAL, BY ANTI-INFLAMMATORY DRUGS, IN 2022

FIGURE 16: GLOBAL DRY EYE DISEASE MARKET, BY CYCLOSPORINE, 2023-2032 (IN $ MILLION)

FIGURE 17: GLOBAL DRY EYE DISEASE MARKET, BY CORTICOSTEROID, 2023-2032 (IN $ MILLION)

FIGURE 18: GLOBAL DRY EYE DISEASE MARKET, BY OTHER ANTI-INFLAMMATORY DRUGS, 2023-2032 (IN $ MILLION)

FIGURE 19: GLOBAL DRY EYE DISEASE MARKET, BY ARTIFICIAL TEARS, 2023-2032 (IN $ MILLION)

FIGURE 20: GLOBAL DRY EYE DISEASE MARKET, BY PUNCTAL PLUGS, 2023-2032 (IN $ MILLION)

FIGURE 21: GLOBAL DRY EYE DISEASE MARKET, BY SECRETAGOGUES, 2023-2032 (IN $ MILLION)

FIGURE 22: GLOBAL DRY EYE DISEASE MARKET, BY OTHER PRODUCTS, 2023-2032 (IN $ MILLION)

FIGURE 23: GLOBAL DRY EYE DISEASE MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2022

FIGURE 24: GLOBAL DRY EYE DISEASE MARKET, BY HOSPITAL PHARMACIES, 2023-2032 (IN $ MILLION)

FIGURE 25: GLOBAL DRY EYE DISEASE MARKET, BY INDEPENDENT PHARMACIES AND DRUGSTORES, 2023-2032 (IN $ MILLION)

FIGURE 26: GLOBAL DRY EYE DISEASE MARKET, BY ONLINE PHARMACIES, 2023-2032 (IN $ MILLION)

FIGURE 27: NORTH AMERICA DRY EYE DISEASE MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 28: UNITED STATES DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 29: CANADA DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 30: EUROPE DRY EYE DISEASE MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 31: UNITED KINGDOM DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 32: GERMANY DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 33: FRANCE DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 34: ITALY DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 35: BELGIUM DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 36: SPAIN DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 37: POLAND DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 38: REST OF EUROPE DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 39: ASIA-PACIFIC DRY EYE DISEASE MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)

FIGURE 40: CHINA DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 41: JAPAN DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 42: INDIA DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 43: SOUTH KOREA DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 44: INDONESIA DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 45: THAILAND DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 46: VIETNAM DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 47: AUSTRALIA & NEW ZEALAND DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 48: REST OF ASIA-PACIFIC DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 49: REST OF WORLD DRY EYE DISEASE MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)

FIGURE 50: LATIN AMERICA DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 51: MIDDLE EAST & AFRICA DRY EYE DISEASE MARKET, 2023-2032 (IN $ MILLION)

FAQ’s

FAQs

The symptoms of dry eye disease range from minor to severe burning, eye fatigue, itching, irritation, and vision loss.

Anti-inflammatory drugs are the largest revenue-generating product in the global dry eye disease market.

Online pharmacies are the fastest-growing distribution channel in the global dry eye disease market.